Manting Liu
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 5
- Oncology 9
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Bihui Cao (9 shared papers)Cheng Zhi (4 shared papers)Baoxia Liang (3 shared papers)Zhenfeng Zhang (5 shared papers)Wu Qingde (3 shared papers)Xiaojun Chang (1 shared paper)Shuo Yang (3 shared papers)Xiaodie Ye (3 shared papers)
In The Last Decade
Manting Liu
46 papers receiving 890 citations
Manting Liu's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 468
- Immunology 160
- Hepatology 72
- Reproductive Medicine 38
- Cancer Research 45
Countries citing papers authored by Manting Liu
This map shows the geographic impact of Manting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manting Liu more than expected).
Fields of papers citing papers by Manting Liu
This network shows the impact of papers produced by Manting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manting Liu. The network helps show where Manting Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Manting Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin Hit paper breakdown → | 2021 | 260 |
| 2 | 2022 | 93 | |
| 3 | 2017 | 86 | |
| 4 | 2021 | 86 | |
| 5 | 2020 | 84 | |
| 6 | 2018 | 46 | |
| 7 | 2024 | 25 | |
| 8 | 2018 | 24 | |
| 9 | 2023 | 24 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 16 | |
| 12 | 2024 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2023 | 12 | |
| 15 | 2021 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2025 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 7 |
About Manting Liu
Manting Liu is a scholar working on Toxicology, Oncology, Immunology, Global and Planetary Change and Complementary and alternative medicine, having authored 51 papers that have together received 921 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Marine and fisheries research (5 papers), Immune Cell Function and Interaction (3 papers), Traditional Chinese Medicine Analysis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Genetic diversity and population structure (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Oncology (468 citations), Immunology (160 citations), Hepatology (72 citations), Reproductive Medicine (38 citations) and Cancer Research (45 citations). Manting Liu has collaborated with scholars based in China, Macao and Israel. Frequent co-authors include Bihui Cao, Cheng Zhi, Baoxia Liang, Zhenfeng Zhang, Wu Qingde, Xiaojun Chang, Shuo Yang, Xiaodie Ye, Jiahong Dong and Daisy Dandan Wang. Their work appears in journals such as Expert Opinion on Drug Safety, International Journal of Molecular Sciences, Scientific Reports, International Journal of Biological Sciences and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.